MedPath

Quantitative Pupillometry

Not yet recruiting
Conditions
Hydrocephalus
Critical Care
Registration Number
NCT05386303
Lead Sponsor
Nantes University Hospital
Brief Summary

The aim of this study is to assess the diagnostic ability of quantitative pupillometry for the early detection of hydrocephalus during the weaning process of the external ventricular drain.

Detailed Description

Acute hydrocephalus is an emergency often requiring the insertion of an external ventricular drain (EVD). In the aftermath, the patient is transferred to an intensive care unit (ICU) for close monitoring. Ensuring optimal cerebral perfusion through efficient drainage of cerebrospinal fluid while minimizing drainage duration are the objectives of care.

Assessing pupillary light reflex is a key test for the detection of neurological deterioration. For long, this assessment has been grossly performed via a qualitative approach (present/absence of pupillary light reflex). For a more precise assessment, quantitative pupillometry has been proposed. Pupil size and constriction speed in response to a standard light are recorded by an automatic portable and user-friendly device. This device is increasingly used in the ICU, mostly for prognostication after acute brain injury. We hypothesized that quantitative pupillometry parameters may vary when hydrocephalus occurs.

The aim of this study is to assess whether quantitative pupillometry parameters vary when hydrocephalus occurs. The investigators focused on the early detection of hydrocephalus during the EVD weaning process.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
60
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
NPi (Neurological Pupil index) and EVD (external ventricular drain)occlusion test5 days

NPi will be compared between two groups of patients (constituted a posteriori): success and failure of the EVD occlusion test.

Independently of this study, the EDV occlusion test starts as soon as prescribed by the physician as a prerequisite before its withdrawal.

Failing an occlusion test is defined by the need for reopening the EVD.

Secondary Outcome Measures
NameTimeMethod
Dilatation velocity5 days

Dilation velocity will be compared between two groups of patients (constituted a posteriori): success and failure of the occlusion test.

Latency of contraction5 days

Latency of contraction will be compared between two groups of patients (constituted a posteriori): success and failure of the occlusion test.

Maximum constriction velocity5 days

Maximum constriction velocity will be compared between two groups of patients (constituted a posteriori): success and failure of the occlusion test.

Pupil size variation5 days

Pupil size variation will be compared between two groups of patients (constituted a posteriori): success and failure of the occlusion test.

Diagnostic evaluation5 days

Pupillometer ability to detect an EDV occlusion test failure will be studied. The area under the ROC curve (AUCROC) will be determined. We define, a priori, that the detection performance will be, respectively, honorable, good or excellent if the AUCROC is higher than 0.70, 0.80 and 0.90.

Pupillometry and EVD occlusion test5 days

Constriction velocity will be compared between two groups of patients (constituted a posteriori): success and failure of the occlusion test.

Pupillometry and clinical scores5 days

The association between pupillometry parameters and clinical scores (Glasgow Coma Scale, FOUR score, RASS and CAM-ICU) will be studied

The association between pupillometry parameters and ventricular volume will be studied.5 days

A relationship between, measurements of ventricular volumes (via brain imaging examinations performed regardless of this study) and pupillometry parameters will be sought

Trial Locations

Locations (2)

Nantes University Hospital

🇫🇷

Nant, Loire-Atlantique, France

CHU de Nantes

🇫🇷

Nantes, France

© Copyright 2025. All Rights Reserved by MedPath